Tatiana Schlossberg, President John F. Kennedy's granddaughter, has died. Here's what to know about acute myeloid leukemia ...

Soley Therapeutics has secured $200 million in series C funds, which the artificial-intelligence-enabled biotech plans to use ...

Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...

The combination therapy, referred to as DAGO+m, yielded a 91% overall response rate and a promising 2-year overall survival ...

Asian patients with newly diagnosed acute myeloid leukemia (AML) may have superior overall survival (OS) outcomes compared with White patients, though further data are needed to corroborate this ...

Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

Acute myelogenous leukemia (AML), also known as acute myeloid leukemia, is a type of cancer that starts in your bone marrow (the soft, spongy tissue inside the bones that makes blood cells). AML is ...

A little over a month after revealing to the world that she'd been diagnosed with cancer, Tatiana Schlossberg has died at age 35. "Our beautiful Tatiana passed away this morning," her family wrote in ...

Amgen acquires Dark Blue Therapeutics for up to $840 million, adding early-stage leukemia drug research and strengthening its oncology discovery pipeline.

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...